UK suspends hydroxychloroquine test for COVID-19

Officials said there were “emerging concerns” over the use of the drug.

London (Reuters):

The UK drug regulator on Tuesday directed scientists to suspend the recruitment of participants to try the use of the malaria drug hydroxychloroquine for the treatment or prevention of COVID-19.

The Medicines and Healthcare Products Regulatory Agency (MHRA) said it is following “emerging concerns” about drug use, and also cited a UK trial, in which hospitalized patients with COVID-19 No significant mortality was found in.

(Except for the headline, this story has not been edited by NDTV staff and published from a syndicated feed.)

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *